Unresolved disorder model. using A
ATOM    294  CG ALYS    38       2.791  61.492  -4.299  0.50 82.33           C  
Unresolved disorder model. using A
ATOM    295  CG BLYS    38       5.466  62.738  -4.326  0.50 83.15           C  
Unresolved disorder model. using A
ATOM    296  CD ALYS    38       2.330  60.762  -5.588  0.50 81.92           C  
Unresolved disorder model. using A
ATOM    297  CD BLYS    38       4.999  64.168  -4.618  0.50 83.01           C  
Unresolved disorder model. using A
ATOM    298  CE ALYS    38       1.176  59.794  -5.332  0.50 81.19           C  
Unresolved disorder model. using A
ATOM    299  CE BLYS    38       6.186  65.003  -5.119  0.50 83.20           C  
Unresolved disorder model. using A
ATOM    300  NZ ALYS    38       0.352  60.197  -4.175  0.50 80.68           N  
Unresolved disorder model. using A
ATOM    301  NZ BLYS    38       5.860  66.432  -5.363  0.50 83.16           N  
Unresolved disorder model. using A
ATOM    609  CG AGLU    77       0.870  62.706  22.086  0.50 66.10           C  
Unresolved disorder model. using A
ATOM    610  CG BGLU    77       0.824  62.692  22.066  0.50 65.95           C  
Unresolved disorder model. using A
ATOM    611  CD AGLU    77       0.304  63.365  23.344  0.50 67.12           C  
Unresolved disorder model. using A
ATOM    612  CD BGLU    77       0.149  63.226  20.804  0.50 66.12           C  
Unresolved disorder model. using A
ATOM    613  OE1AGLU    77      -0.937  63.400  23.502  0.50 66.51           O  
Unresolved disorder model. using A
ATOM    614  OE1BGLU    77      -0.295  62.403  19.967  0.50 67.73           O  
Unresolved disorder model. using A
ATOM    615  OE2AGLU    77       1.113  63.859  24.168  0.50 68.19           O  
Unresolved disorder model. using A
ATOM    616  OE2BGLU    77       0.060  64.471  20.651  0.50 67.99           O  
Unresolved disorder model. using A
ATOM   1129  CG APHE   142      25.097  62.598  13.395  0.50 79.94           C  
Unresolved disorder model. using A
ATOM   1130  CG BPHE   142      26.101  62.338  15.963  0.50 80.01           C  
Unresolved disorder model. using A
ATOM   1131  CD1APHE   142      25.749  63.040  12.252  0.50 80.14           C  
Unresolved disorder model. using A
ATOM   1132  CD1BPHE   142      25.898  61.438  17.000  0.50 80.19           C  
Unresolved disorder model. using A
ATOM   1133  CD2APHE   142      23.736  62.875  13.528  0.50 79.81           C  
Unresolved disorder model. using A
ATOM   1134  CD2BPHE   142      26.478  63.640  16.282  0.50 79.96           C  
Unresolved disorder model. using A
ATOM   1135  CE1APHE   142      25.052  63.681  11.238  0.50 80.25           C  
Unresolved disorder model. using A
ATOM   1136  CE1BPHE   142      26.101  61.819  18.309  0.50 80.16           C  
Unresolved disorder model. using A
ATOM   1137  CE2APHE   142      23.040  63.518  12.522  0.50 79.89           C  
Unresolved disorder model. using A
ATOM   1138  CE2BPHE   142      26.677  64.013  17.592  0.50 79.91           C  
Unresolved disorder model. using A
ATOM   1139  CZ APHE   142      23.695  63.920  11.375  0.50 80.01           C  
Unresolved disorder model. using A
ATOM   1140  CZ BPHE   142      26.488  63.109  18.602  0.50 79.98           C  
Unresolved disorder model. using A
ATOM   3800  CG AMET   476      21.561  37.302  26.243  0.50 81.52           C  
Unresolved disorder model. using A
ATOM   3801  CG BMET   476      21.433  37.235  26.290  0.50 80.62           C  
Unresolved disorder model. using A
ATOM   3802  SD AMET   476      23.296  36.983  26.565  0.50 84.36           S  
Unresolved disorder model. using A
ATOM   3803  SD BMET   476      20.984  36.340  24.769  0.50 81.25           S  
Unresolved disorder model. using A
ATOM   3804  CE AMET   476      24.101  37.814  25.208  0.50 83.72           C  
Unresolved disorder model. using A
ATOM   3805  CE BMET   476      20.292  34.818  25.392  0.50 80.65           C  

1